🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pre-exposure Prophylaxis

Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County NCT07467018n/a1 site📍 Santa Monica University of California, Los Angeles · Tests: Community-based healthcare delivery, Lenacapavir Vienna HIV Infection Via Sex Study NCT05326061n/a1 site📍 Vienna Medical University of Vienna Gathering Online for Dialogue and Discussion to Enhance Social Support NCT05753683NA1 site📍 Durham RTI International · Tests: mHealth-Women's CoOp, Virtual Group Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence NCT07772791NA1 site📍 Rio de Janeiro Oswaldo Cruz Foundation · Tests: Weekly WhatsApp Adherence Messages Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP NCT07218211Phase 41 site📍 Durham Duke University · Tests: Lenacapavir long-acting Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial NCT06485154Phase 43 sites📍 Johannesburg📍 Durban📍 Cape Town University of Witwatersrand, South Africa · Tests: TLD - Tenofovir Disoproxil Fumarate / Lamivudine / Dolutegravir Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO) NCT04762134NA6 sites📍 Calgary📍 Vancouver📍 Hamilton Jonathan Troy Grennan · Tests: Doxycycline Hyclate Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs NCT07199335Phase 42 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: APRETUDE (cabotegravir) HIV Prevention With PrEP Among People on Opioid Replacement Therapy NCT07160075Phase 46 sites📍 Calgary📍 Regina📍 Saskatoon Cara Spence · Tests: Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI) NCT07683117NA1 site📍 Del Mar EMPOWERX INC · Tests: PEPPI Pharmacies Stick2PrEP Cisgender Women and Trans Individuals NCT05165745NA1 site📍 New York Columbia University · Tests: Individualized Feedback The SwissPrEPared Study NCT03893188n/a41 sites📍 Aarau📍 Baden📍 Basel University of Zurich Predictors of Health Service Utilizations Among Key Population in Washington DC NCT06046079n/a1 site📍 Washington D.C. Us Helping Us, People Into Living, Inc. Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders NCT06158607NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders, Standard of care treatment Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention NCT06370923NA1 site📍 Mutare University of Stellenbosch · Tests: Peer Distribution, Community Health Worker Distribution Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT NCT06250504Phase 31 site📍 Somkele Africa Health Research Institute · Tests: APRETUDE (cabotegravir) 600 mg\3 mL, DAPIRING (Dapivirine) 25mg Vaginal Ring, tenofovir disoproxil and emtricitabine, T… Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions NCT06558825NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Integrated Intervention to Promote PrEP Uptake, Standard Treatment Condition The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir NCT05515770Phase 31 site📍 Rio de Janeiro Evandro Chagas National Institute of Infectious Disease · Tests: Cabotegravir Injection BetterInfo on Women's PrEP Choices and Outcomes in Malawi NCT07579754NA1 site📍 Blantyre Johns Hopkins Bloomberg School of Public Health · Tests: Tracing Strategy Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain NCT06860945n/a26 sites📍 Almería📍 Cadiz📍 Cartagena Hospital Universitario de Valme · Tests: No Intervention: Observational Cohort PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa. NCT06807736n/a1 site📍 Cape Town Desmond Tutu HIV Foundation · Tests: Cabotegravir long-acting, Tenofovir emtricitabine, Dapivirine containing vaginal ring PathToScale: The PERSIST Trial NCT07221747NA1 site📍 Lilongwe Georgetown University · Tests: Standard of Care (SoC), Enhanced continuation support package HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy NCT06919419NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Multicomponent strategy Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP NCT05669534Phase 41 site📍 New Haven University of Connecticut · Tests: community-friendly health recovery program, Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico NCT05804461NA1 site📍 San Juan University of Puerto Rico · Tests: Motivational Interviewing Finishing HIV Project NCT06406049NA1 site📍 Miami University of Miami · Tests: Control group-Standard Health Promotion, Social network intervention Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine NCT06885853n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention NCT04855773NA4 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Public Health Foundation Enterprises, Inc. · Tests: PrEPmate, Dot Diary Point of Care STI Testing NCT06844045NA1 site📍 Philadelphia Icahn School of Medicine at Mount Sinai · Tests: Gonorrhea/chlamydia Point-of-Care Testing Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services NCT07438041NA4 sites📍 San Francisco📍 Atlanta📍 Baltimore Westat · Tests: LYPS, Enhanced Standard of Care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy